Hypertension (high blood pressure) Board decisions

The Board denied an initial compensable rating for the service-connected dermatitis and remanded claims for service connection, a rating for hypertension, and a combined evaluation.

The Board denied the Veteran's claim for an initial compensable disability rating for hypertension as there was no evidence of diastolic pressure predominantly 100 or more, systolic pressure predominantly 160 or more, or a history of diastolic pressure predominantly 100 or more requiring continuous medication for control.

The Board denied service connection for the cause of death, finding that neither diabetes mellitus nor hypertension was a principal or contributory cause of the Veteran's death.

The Board granted earlier effective dates of December 21, 2022, for the grants of service connection for adjustment disorder, arteriosclerotic heart disease, scars of the anterior trunk, scars of the left lower extremity, and hypertension (HTN).

The Board granted a total disability based upon individual unemployability (TDIU) and denied a compensable rating for hypertension. The service connection claims for thyroid disorder and heart disability were remanded.

The Board denied the Veteran's claims for earlier effective dates for increased ratings and service connection, as well as remanded several new claims.

The Board denied service connection for diabetic peripheral neuropathy, left and right lower extremities, erectile dysfunction, a rating in excess of 70 percent for depressive disorder, and secondary conditions as the evidence did not support a diagnosis or nexus to service or service-connected disability.

The Board remands the claim for an initial compensable disability rating for hypertension to provide the Veteran with notice of his right to a hearing.

The Board granted service connection for obstructive sleep apnea and hypertension, but denied service connection for chronic fatigue syndrome (CFS) and type II diabetes mellitus.

The Board remands the claims for service connection for high blood pressure and sleep apnea to schedule VA examinations.

The Board denied service connection for bilateral knee disability, bilateral lower extremity peripheral neuropathy, and erectile dysfunction as new and relevant evidence was not received. The Veteran's hypertension does not warrant a compensable rating.

The Board granted service connection for hypertension and a 10 percent rating for bilateral Meibomian gland dysfunction (claimed as burning eyes).

The Board granted service connection for obstructive sleep apnea, type II diabetes mellitus, and hypertension based on the evidence showing a secondary relationship to the Veteran's service-connected posttraumatic stress disorder (PTSD).

The Veteran's claim for an earlier effective date of December 27, 2021, and no earlier, for the award of service connection for unspecified dermatitis was granted. The initial rating in excess of 10 percent for unspecified dermatitis was denied.

The Veteran's service-connected disabilities have rendered him unable to obtain and maintain substantially gainful employment from August 10, 2021.

The Board dismissed all claims for service connection and increased ratings due to the Veteran's death during the pendency of the appeal.

The appeals for service connection and higher ratings were dismissed due to procedural defects.

The Veteran's hypertension has been granted a 10 percent disability rating, but no higher, from September 17, 2024. The claim for service connection for a separate disability secondary to hypertension is being remanded.

The Board granted service connection for hypertension, coronary artery disease, asthma, transient ischemic attack, neurocognitive disorder (dementia), and acquired psychiatric disorder (other specified depressive disorder) but denied service connection for renal toxicity. Several issues were remanded.

The Board remands the claims for service connection for diabetes mellitus, gastrointestinal reflux disease, and hypertension to afford the Veteran appropriate examinations.